Cognitive Disorder Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Cognitive Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting

Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)

Neurocognitive Disorders
Centre Hospitalier Universitaire de Nice100 enrolled1 locationNCT05943834
Recruiting

Lombard Cohort of Brain Health Services

Alzheimer s DiseaseSubjective Cognitive Decline (SCD)Functional Cognitive Disorder+1 more
University of Milano Bicocca1,000 enrolled5 locationsNCT07457138
Recruiting
Phase 3

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Cognitive Impairment, MildApathy in DementiaApathy+2 more
KompanionCare SAS80 enrolled5 locationsNCT07237009
Recruiting
Not Applicable

Breast Cancer and Chemobrain : Effects of Photobiomodulation on the Improvement of Perceived Cognitive Impairment

OncologySupport CareCognitive Disorders
Centre Hospitalier de Valenciennes200 enrolled1 locationNCT06995443
Recruiting
Not Applicable

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

DementiaAlzheimer DiseaseCommunication Disorders+11 more
University of Texas at Austin60 enrolled3 locationsNCT05741853
Recruiting

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Cognitive ImpairmentDementiaCognitive Dysfunction+7 more
Mclean Hospital40 enrolled1 locationNCT05245903
Recruiting
Not Applicable

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

DementiaBrain DiseasesCentral Nervous System Diseases+5 more
Advanced Technology & Communications158 enrolled11 locationsNCT06088121
Recruiting

Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders

Neurocognitive DisordersAlzheimer's Disease
University Hospital, Rouen140 enrolled1 locationNCT07205003
Recruiting
Phase 1Phase 2

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

HealthyHIV Associated Neurocognitive DisorderHIV Dementia+1 more
Yale University70 enrolled1 locationNCT05586581
Recruiting

Outcomes of ICT Assistive Technology in RehabiliTAtIoN Pathways

Communication Aids for DisabledCommunication DisordersMotor Disorders+1 more
Fondazione Don Carlo Gnocchi Onlus50 enrolled1 locationNCT06546813
Recruiting

Biobank and Brain Health in Bordeaux.

DementiaBrain DiseasesDepression+12 more
University Hospital, Bordeaux2,050 enrolled1 locationNCT05322343
Recruiting
Not Applicable

Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials

Cognitive Disorders
Centre Hospitalier Universitaire Dijon72 enrolled1 locationNCT05888961
Recruiting
Not Applicable

rTMS for Apathy Clinical Trial

DementiaAlzheimer DiseaseMild Cognitive Impairment+3 more
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT05561205
Recruiting
Phase 2

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Mild Cognitive ImpairmentAmnestic Mild Cognitive ImpairmentAmnestic Mild Cognitive Disorder+2 more
University of Texas Southwestern Medical Center75 enrolled1 locationNCT05446584
Recruiting
Not Applicable

Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis

Cognitive DisordersMultiple SclerosisTelerehabilitation+1 more
Universita di Verona60 enrolled1 locationNCT06964581
Recruiting
Not Applicable

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

Patient SatisfactionAlzheimer DiseaseCaregiver Burden+7 more
University of Michigan3,000 enrolled7 locationsNCT05929703
Recruiting

CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes

Neurocognitive Disorders
University of Manitoba225 enrolled3 locationsNCT05754567
Recruiting
Not Applicable

Exergaming Revolution in Dementia

Alzheimer DiseaseParkinson DiseaseLewy Body Dementia+2 more
Eastern Switzerland University of Applied Sciences48 enrolled1 locationNCT06631742
Recruiting
Not Applicable

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

Deep Brain StimulationMild Cognitive ImpairmentMild Alzheimer's Disease+1 more
University of California, Los Angeles144 enrolled1 locationNCT05417555